ClassID:

20476

A61K31/575 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Recent Application in this class:
#301
20230141609
2023-05-11

Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms

#302
20230134958
2023-05-04

NEW MEDICAL TREATMENT

#303
20230130602
2023-04-27

Inhibitors of spore germination

#304
20230129151
2023-04-27

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELIN RELATED AND INFLAMMATION RELATED DISEASES OR DISORDERS

#305
20230128120
2023-04-27

OMEGA MURICHOLIC ACID AS A PREGNANE X RECEPTOR LIGAND FOR TREATING HEPATO-INTESTINAL DISEASES

#306
20230128105
2023-04-27

PHYTOECDYSONES AND DERIVATIVES THEREOF FOR USE IN TREATING DISORDERED RESPIRATORY FUNCTION ON VIRAL INFECTION

#307
20230125585
2023-04-27

DOSING PROTOCOLS AND REGIMENS FOR AMINOSTEROL TREATMENT

#308
20230123701
2023-04-20

HUMAN AMINOSTEROL ENT-03 COMPOUNDS, RELATED COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME

#309
20230122393
2023-04-20

STEROIDAL NITRONE F2 FOR USE IN THE PREVENTION AND/OR TREATMENT OF PERMANENT CEREBRAL ISCHAEMIA

#310
20230119819
2023-04-20

Tripartite Modulators of Endosomal G Protein-Coupled Receptors

#311
20230117905
2023-04-20

PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES

#312
20230117286
2023-04-20

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NONALCOHOLIC STEATOHEPATITIS

#313
20230114753
2023-04-13

USE OF A GROUP OF MARKERS FOR DIAGNOSING AND ADJUSTING TREATMENT OF PRIMARY BILIARY CHOLANGITIS, PHARMACEUTICAL COMPOSITION AND SOLID DOSAGE FORM FOR TREATING PRIMARY BILIARY CHOLANGITIS

#314
20230113666
2023-04-13

Compositions and methods for treating CNS disorders

#315
20230111190
2023-04-13

ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME

#316
20230109432
2023-04-06

IBAT inhibitors for the treatment of liver diseases

#317
20230105108
2023-04-06

COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS

#318
20230103889
2023-04-06

TREATMENT AND PREVENTION OF CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION

#319
20230103366
2023-04-06

Combination therapies and methods of use thereof for treating cancer

#320
20230100089
2023-03-30

Methods and composition for induction of immune response

#321
20230091702
2023-03-23

USE OF BILE ACIDS AND DERIVATIVES THEREOF IN PREPARATION OF GPR39 AGONIST

#322
20230087305
2023-03-23

Methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases

#323
20230077636
2023-03-16

INTRAVENOUS FORMULATIONS OF RK-33

#324
20230071157
2023-03-09

Pharmaceutical compositions and methods of treating cardiovascular diseases

#325
20230061134
2023-03-02

METHODS AND COMPOSITIONS FOR STIMULATION AND ENHANCEMENT OF REGENERATION OF TISSUES

#326
20230060715
2023-03-02

USE OF FXR AGONISTS FOR TREATING AN INFECTION BY HEPATITIS D VIRUS

#327
20230047788
2023-02-16

Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

#328
20230046998
2023-02-16

Composition for preventing or treating keloid

#329
20230041859
2023-02-09

USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#330
20230040386
2023-02-09

URSODEOXYCHOLIC ACID-CONTAINING AGENT FOR TREATING OR PREVENTING PRESBYOPIA

#331
20230033795
2023-02-02

NEW THERAPY

#332
20230031648
2023-02-02

TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS

#333
20230030932
2023-02-02

CELL SURFACE ANCHORING ANTIGEN CONJUGATES TO TREAT CANCER

#334
20230016551
2023-01-19

METHOD FOR ADMINISTRATION OF URSODEOXYCHOLIC ACID

#335
20230000924
2023-01-05

COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY

#336
20220409632
2022-12-29

Compositions and methods for the repair of myelin

#337
20220409631
2022-12-29

METHODS OF INDUCING OR ENHANCING FARNESOID X RECEPTOR (FXR)-MEDIATED TRANSCRIPTIONAL RESPONSE

#338
20220401554
2022-12-22

USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES

#339
20220395462
2022-12-15

Compositions and methods for the treatment and prophylaxis of surgical site infections

#340
20220387450
2022-12-08

COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS

#341
20220387449
2022-12-08

Treatment of submental fat

#342
20220387305
2022-12-08

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

#343
20220378804
2022-12-01

Compositions and methods of clostridiodides difficile treatment, decolonization, and prevention

#344
20220378803
2022-12-01

INJECTABLE COMPOSITIONS OF URSODEOXYCHOLIC ACID

#345
20220378802
2022-12-01

TREATMENT OF ALCOHOLIC HEPATITIS

#346
20220378786
2022-12-01

METHODS OF DEFINING FUNCTIONAL CHANGE AND SLOWING PROGRESSION IN CHRONIC LIVER DISEASE

#347
20220362263
2022-11-17

TREATMENT FOR FIBROSIS AND INHIBITION OF FIBROSIS

#348
20220362260
2022-11-17

METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET

#349
20220362238
2022-11-17

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

#350
20220354849
2022-11-10

COMPOSITION FOR PREVENTING OR TREATING METABOLIC LIVER DISEASE

#351
20220348888
2022-11-03

Cultivation of human noroviruses

#352
20220347190
2022-11-03

TREATMENT COMPRISING FXR AGONISTS

#353
20220339136
2022-10-27

LIPOSOMAL TROPONOID COMPOUND FORMULATIONS

#354
20220331341
2022-10-20

TREATMENT COMPRISING THE USE OF FXR AGONISTS

#355
20220331266
2022-10-20

CBD COMPOSITION

#356
20220323551
2022-10-13

COMPOSITION FOR PREVENTING, TREATING, OR AMELIORATING VIRAL INFECTION DISEASE, CONTAINING ACTIVE OXYGEN PRODUCTION INHIBITOR AND ACTIVE OXYGEN SCAVENGER COMPLEX AS ACTIVE INGREDIENTS

#357
20220323383
2022-10-13

SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF

#358
20220313706
2022-10-06

COMPOSITION COMPRISING STEROL DERIVATIVES FOR USE IN THE TREATMENT OF A NEURONAL PATHOLOGY RELATED TO HYPOXIA, HYPOGLYCEMIA AND/OR HYPERGLYCEMIA

#359
20220305031
2022-09-29

METHODS FOR REDUCING TUMOR PROGRESSION AND FIBROSIS AND INCREASING ADAPTIVE IMMUNITY IN MALIGNANCIES

#360
20220304937
2022-09-29

PEDIATRIC FORMULATION

#361
20220296611
2022-09-22

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER

#362
20220288133
2022-09-15

COMPOSITIONS FOR THE TREATMENT OF CONDITIONS BY DERMAL FILLERS

#363
20220281912
2022-09-08

COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE

#364
20220280534
2022-09-08

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#365
20220280533
2022-09-08

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#366
20220280514
2022-09-08

METHODS OF TREATING BILE ACID DIARRHEA

#367
20220273801
2022-09-01

COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION

#368
20220273675
2022-09-01

BILE ACID DERIVATIVE, COMPOSITION AND APPLICATION THEREOF

#369
20220265776
2022-08-25

COMBINATION

#370
20220265619
2022-08-25

COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS

#371
20220257612
2022-08-18

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

#372
20220257513
2022-08-18

Insoluble active substance carrier comprising transfersome

#373
20220249516
2022-08-11

Optimizing Mifepristone Absorption

#374
20220241376
2022-08-04

METHOD FOR DECREASING ADVERSE-EFFECTS OF INTERFERON

#375
20220241373
2022-08-04

METHODS AND USES FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES

#376
20220241316
2022-08-04

25-HYDROXYCHOLESTEROL (25HC), CRYAB AGGREGATION INHIBITOR, IS A NOVEL SENOLYTIC

#377
20220241295
2022-08-04

PHARMACEUTICAL COMPOSITION CONTAINING BREXANOLONE, GANAXOLONE, OR ZURANOLONE, AND USE THEREOF

#378
20220233699
2022-07-28

COMPOSITIONS COMPRISING FUSIDIC ACID AND PACKAGES THEREFOR

#379
20220233553
2022-07-28

CELLULAR SENESCENCE ACTIVATING COMPOUNDS

#380
20220233552
2022-07-28

Methods and compositions for the treatment of IL13Ra2—overexpressing cancer

#381
20220226367
2022-07-21

THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION

#382
20220226350
2022-07-21

PHARMACEUTICAL COMPOSITIONS COMPRISING A FXR AGONIST AND A FIBRATE FOR USE IN THE TREATMENT OF CHOLESTATIC LIVER DISEASE

#383
20220220150
2022-07-14

Compositions and methods for treating CNS disorders

#384
20220220148
2022-07-14

METHODS AND COMPOSITIONS FOR STIMULATION OF THE INTESTINAL ENTEROENDOCRINE SYSTEM FOR TREATING DISEASES OR CONDITIONS RELATED TO THE SAME

#385
20220213137
2022-07-07

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

#386
20220202881
2022-06-30

Bile acids and use in disease treatment

#387
20220202766
2022-06-30

CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT

#388
20220184099
2022-06-16

METHODS OF USING OBETICHOLIC ACID

#389
20220184089
2022-06-16

Pharmaceutical compositions and methods of treating cardiovascular diseases

#390
20220175869
2022-06-09

FORMULATIONS INHIBITING SARS-CoV-2 VIRUS

#391
20220175851
2022-06-09

COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH

#392
20220175799
2022-06-09

COMPOSITIONS HAVING THE ABILITY TO PROMOTE HEALTHY CHOLESTEROL LEVELS

#393
20220175798
2022-06-09

COMPOSITIONS COMPRISING OXYGENATED CHOLESTEROL SULFATE AND AT LEAST ONE OF POLYALKYLENE GLYCOL, CARBOXYMETHYL CELLULOSE AND POLYOXYLGLYCERIDE

#394
20220168324
2022-06-02

CANCER THERAPY

#395
20220168219
2022-06-02

Liquid depot for non-invasive sustained delivery of agents to the eye

#396
20220160733
2022-05-26

Compositions for improving cell viability and methods of use thereof

#397
20220160732
2022-05-26

PHYTOECDYSONES AND THE DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES

#398
20220160731
2022-05-26

COMPOSITIONS COMPRISING BIOLOGICALLY ACTIVE AGENTS AND BILE SALTS

#399
20220152124
2022-05-19

Application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep

#400
20220152060
2022-05-19

PHYTOECDYSONES AND THE DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF IMPAIRED LUNG FUNCTION

#401
20220152059
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#402
20220152058
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#403
20220152057
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#404
20220152056
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#405
20220152055
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#406
20220152054
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#407
20220152053
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#408
20220152052
2022-05-19

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#409
20220152051
2022-05-19

APPLICATION OF GLYCOCHOLIC ACID IN PREPARATION OF ANTITUMOR DRUGS

#410
20220143031
2022-05-12

Oxindoles and methods of use thereof

#411
20220142942
2022-05-12

Cannabinoid pouches

#412
20220135967
2022-05-05

TUNABLE ENDOGENOUS PROTEIN DEGRADATION

#413
20220133852
2022-05-05

Reconstituted high density lipoprotein formulation and production method thereof

#414
20220133746
2022-05-05

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

#415
20220133745
2022-05-05

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

#416
20220133744
2022-05-05

COMPOSITION OF LANOSTEROL PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

#417
20220133743
2022-05-05

Topical treatment of wounds with statins and cholesterol for scar reduction

#418
20220125805
2022-04-28

Biologically active ganoderma lucidum compounds and synthesis of anticancer derivatives; ergosterol peroxide probes for cellular localization

#419
20220118041
2022-04-21

Blend of Plant-Extracted Oils

#420
20220117978
2022-04-21

Compositions of bile acids and phenylbutyrate compounds

#421
20220110948
2022-04-14

COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF

#422
20220110920
2022-04-14

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS

#423
20220104517
2022-04-07

METHODS AND COMPOSITIONS FOR TREATING INTESTINAL DISORDER

#424
20220096510
2022-03-31

METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE PREVENTION OF RECURRENT INFECTIONS CAUSED BY CLOSTRIDIUM DIFFICILE

#425
20220096497
2022-03-31

Ursodeoxycholic acid-containing agent for treating or preventing presbyopia

#426
20220088036
2022-03-24

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

#427
20220087934
2022-03-24

TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS

#428
20220079956
2022-03-17

MAINTENANCE OF AGING MUSCLE TISSUE

#429
20220079895
2022-03-17

COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES

#430
20220072012
2022-03-10

URSODEOXYCHOLIC ACID-CONTAINING AGENT FOR TREATING OR PREVENTING PRESBYOPIA

#431
20220072011
2022-03-10

TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF

#432
20220071895
2022-03-10

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

#433
20220062421
2022-03-03

TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION

#434
20220062369
2022-03-03

Edible blended vegetable oil for reducing blood lipids and cholesterol

#435
20220062297
2022-03-03

Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

#436
20220062231
2022-03-03

Treatment for primary biliary cholangitis

#437
20220054506
2022-02-24

Immunoregulatory agent

#438
20220054505
2022-02-24

Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration

#439
20220054495
2022-02-24

Compositions and methods for enhanced delivery of antiviral agents

#440
20220054429
2022-02-24

COMPOSITIONS COMPRISING CANNABIDIOL AND SECOND THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

#441
20220054406
2022-02-24

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

#442
20220047704
2022-02-17

Inactivating bacteria with electric pulses and antibiotics

#443
20220047499
2022-02-17

Topical Lipolysis Composition and Methods

#444
20220040204
2022-02-10

Aramchol salts

#445
20220040174
2022-02-10

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#446
20220040126
2022-02-10

Methods and compositions for the treatment of cytoplasmic glycogen storage disorders

#447
20220034915
2022-02-03

METHODS FOR MONITORING TREATMENT OF CHRONIC LIVER DISEASE

#448
20220031721
2022-02-03

Skin barrier composition

#449
20220031711
2022-02-03

Methods for attenuating graft-versus-host disease and opportunistic infections

#450
20220031640
2022-02-03

Formulations for epidermal repair

#451
20220024961
2022-01-27

METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS

#452
20220023315
2022-01-27

METHODS OF ACTIVATING MICROGLIAL CELLS

#453
20220023314
2022-01-27

STABLE FORMULATIONS OF ANESTHETICS AND ASSOCIATED DOSAGE FORMS

#454
20220023256
2022-01-27

Pharmaceutical composition to treat health conditions associated with elevated glucose levels

#455
20220016200
2022-01-20

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS

#456
20220016138
2022-01-20

SYNTHETIC DERIVATIVES OF CHOLIC ACID 7-SULFATE AND USES THEREOF

#457
20220016136
2022-01-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISORDERS

#458
20220000791
2022-01-06

MULTI-LAYERED PARTICLES

#459
20210403607
2021-12-30

CYCLODEXTRIN DIMERS AND USES THEREOF

#460
20210401836
2021-12-30

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#461
20210395674
2021-12-23

COMPOSITION FOR INCREASING BIOLOGICAL ACTIVITY OF STEM CELLS USING MIXTURE 4F

#462
20210395293
2021-12-23

PREPARATION AND USES OF OBETICHOLIC ACID

#463
20210393661
2021-12-23

Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia

#464
20210386762
2021-12-16

THE APPLICATION OF URSODEOXYCHOLIC ACID OR ITS PHARMACEUTICAL SALT IN THE PREPARATION OF AN ANTITUMOR DRUG AND AN ANTITUMOR DRUG

#465
20210386761
2021-12-16

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE, CONTAINING, AS ACTIVE INGREDIENT, TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#466
20210386758
2021-12-16

TOPICAL FORMULATIONS COMPRISING A STEROID

#467
20210379091
2021-12-09

Use of cationic steroidal antimicrobial compounds to deactivate coronavirus

#468
20210379043
2021-12-09

COMBINATION TREATMENT OF LIVER DISORDERS

#469
20210379040
2021-12-09

COMBINATION TREATMENT OF LIVER DISORDERS

#470
20210369737
2021-12-02

PROSTATE FUNCTION SUPPORT FORMULA

#471
20210369736
2021-12-02

Composition for prevention or treatment of allergic disease including inotodiol compound as active ingredient

#472
20210369735
2021-12-02

PHYTOECDYSONES FOR USE IN THE PREVENTION OF MUSCLE STRENGTH LOSS DURING IMMOBILISATION

#473
20210369675
2021-12-02

ANTIMICROBIAL DRUG METHODS OF USE & THERAPEUTIC COMPOSITIONS

#474
20210369606
2021-12-02

Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent

#475
20210353669
2021-11-18

LIPID COMPOSITION CONTAINING MICRONUTRIENTS FOR THE PREVENTION AND/OR TREATMENT OF METABOLIC DISEASES

#476
20210353645
2021-11-18

Methods of treating SARS-CoV-2 infections

#477
20210347811
2021-11-11

Steroid compounds as Treg modulators and uses thereof

#478
20210347810
2021-11-11

STEROL PURIFICATION

#479
20210346401
2021-11-11

REGULATOR OF TGR5 SIGNALING AS IMMUNOMODULATORY AGENT

#480
20210346400
2021-11-11

TREATMENT OF FIBROSIS USING FXR LIGANDS

#481
20210346381
2021-11-11

ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF

#482
20210346338
2021-11-11

CANNABINOID POUCHES

#483
20210340175
2021-11-04

IBAT inhibitors for the treatment of liver diseases

#484
20210338826
2021-11-04

Combination therapy for the treatment of liver disease

#485
20210338691
2021-11-04

METHODS FOR TREATING SLEEP DISORDERS, SLEEP DISTURBANCES, AND RELATED SYMPTOMS USING AMINOSTEROL COMPOSITIONS

#486
20210338690
2021-11-04

COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS

#487
20210330734
2021-10-28

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES

#488
20210330683
2021-10-28

COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS

#489
20210330645
2021-10-28

ANTIBACTERIAL COMBINATIONS

#490
20210330586
2021-10-28

AZOLE COMOPUND OPHTHALMIC PREPARATION

#491
20210322402
2021-10-21

Compositions for treating CMT and related disorders

#492
20210315941
2021-10-14

RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS

#493
20210315908
2021-10-14

Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes

#494
20210315907
2021-10-14

COMPOSITIONS AND METHODS FOR TREATING BRAIN-GUT DISORDERS

#495
20210315842
2021-10-14

STABLE PHARMACEUTICAL COMPOSITIONS FOR PRESSURIZED METERED DOSE INHALERS

#496
20210309731
2021-10-07

Composition of a drug carrier, pharmaceutical composition thereof, preparation method and use method thereof

#497
20210301286
2021-09-30

TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES

#498
20210299148
2021-09-30

Fluorinated bile acid derivatives

#499
20210290710
2021-09-23

Composition for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseases, and method for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseases

#500
20210290638
2021-09-23

Composition and method for promoting normal urinary function

#501
20210290526
2021-09-23

LIPID EMULSION FOR PARENTERAL ADMINISTRATION

#502
20210283166
2021-09-16

USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES

#503
20210275467
2021-09-09

TUMOR REDUCTION FORMULATIONS AND METHODS OF USE THEREOF

#504
20210260078
2021-08-26

LOW DOSAGE INTRANASAL AMINOSTEROL DOSAGE FORMS AND METHODS OF USING THE SAME

#505
20210260024
2021-08-26

Therapy for Inflammatory Linear Verrucous Epidermal Nevus (ILVEN)

#506
20210259967
2021-08-26

TREATMENT OF SEPSIS AND SEPTIC SHOCK

#507
20210252023
2021-08-19

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING THE PROGRESSION AND/OR ONSET OF AGE-RELATED NEURODEGENERATION

#508
20210252022
2021-08-19

COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF VISUAL IMPAIRMENTS COMPRISING URSODEOXYCHOLIC ACID

#509
20210252021
2021-08-19

FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF

#510
20210251922
2021-08-19

Methods and compositions for the treatment of steatosis-associated disorders

#511
20210228665
2021-07-29

Antithrombotic composition comprising Nakai extract

#512
20210228599
2021-07-29

FARNESOID X RECEPTOR MODULATORS

#513
20210220279
2021-07-22

Onapristone extended-release compositions and methods

#514
20210220260
2021-07-22

TOPICAL INJECTABLE COMPOSITION

#515
20210213099
2021-07-15

Carrier composition for eye drops and pharmaceutical composition including the same

#516
20210207095
2021-07-08

METHODS OF ACTIVATING CELLS VIA PTP 1B INHIBITION

#517
20210207086
2021-07-08

Neurogenesis stimulant, internal agent, culture medium additive, cell diluent additive, culture medium, and cell diluent

#518
20210205294
2021-07-08

Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

#519
20210186990
2021-06-24

METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS

#520
20210186989
2021-06-24

ENHANCED TRAINED IMMUNITY IN MYELOID CELLS BY SHIP-1 INHIBITION

#521
20210179660
2021-06-17

GLUCOCORTICOID INHIBITORS FOR TREATMENT OF PROSTATE CANCER

#522
20210177868
2021-06-17

NOVEL USE OF PHYTOSTENONE

#523
20210177867
2021-06-17

Compositions of bile acids and phenylbutyrate compounds

#524
20210177775
2021-06-17

METHOD FOR THE TREATMENT OF FATTY LIVER DISEASE

#525
20210170036
2021-06-10

Oral pharmaceutical composition containing pemetrexed and production method thereof

#526
20210169903
2021-06-10

PHARMACEUTICAL COMPOSITIONS AND METHODS

#527
20210169902
2021-06-10

USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) TO TREAT INFLAMMATORY SKIN DISEASE AND SKIN LESIONS

#528
20210169901
2021-06-10

Treatment for modulating gut microbiota

#529
20210169898
2021-06-10

Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

#530
20210163929
2021-06-03

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC AND METABOLIC DISEASES

#531
20210161932
2021-06-03

TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST

#532
20210161917
2021-06-03

COMPOSITION FOR SUBCUTANEOUS INJECTION, CONTAINING DEOXYCHOLIC ACID, AND PREPARATION METHOD THEREFOR

#533
20210161916
2021-06-03

Compositions and methods for the repair of myelin

#534
20210161913
2021-06-03

OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER

#535
20210161893
2021-06-03

Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

#536
20210147469
2021-05-20

Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis

#537
20210145848
2021-05-20

OXYSTEROLS AND METHODS OF USE THEREOF

#538
20210145822
2021-05-20

Spirolactone compounds

#539
20210145741
2021-05-20

ANTIFIBROTIC COMPOSITION

#540
20210138028
2021-05-13

Treating or preventing adverse liver conditions

#541
20210137960
2021-05-13

COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEAR-PENETRATING ANTIBODIES

#542
20210137946
2021-05-13

Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases

#543
20210137945
2021-05-13

METHOD FOR TREATING A CANCER ASSOCIATED WITH THE ACTIVATION OF GALECTIN-1

#544
20210132069
2021-05-06

METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL

#545
20210128642
2021-05-06

Cholesterol reducing compositions and methods of use thereof

#546
20210128584
2021-05-06

USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

#547
20210128582
2021-05-06

Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis

#548
20210128525
2021-05-06

Treatment for primary biliary cholangitis

#549
20210121612
2021-04-29

Systems for Removing Air from the Fluid Circuits of a Plasma Processing System

#550
20210121611
2021-04-29

Systems for removing air from the fluid circuits of a plasma processing system

#551
20210121502
2021-04-29

USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI

#552
20210121493
2021-04-29

METHODS FOR TREATING LIVER DISEASES

#553
20210121481
2021-04-29

Compounds and methods of promoting myelination

#554
20210121383
2021-04-29

COMPOSITION FOR ANTI-AGING

#555
20210115445
2021-04-22

CHANNEL MODULATORS

#556
20210093561
2021-04-01

DENTAL CARE CANNABIS DEVICE AND USE THEREOF

#557
20210085662
2021-03-25

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING PERSISTENCE AND EXPRESSION OF EPISOMAL VIRUSES

#558
20210085644
2021-03-25

TREATMENT FOR PRIMARY BILIARY CHOLANGITIS

#559
20210077455
2021-03-18

Use of cannabinoids in the treatment of a neurodegenerative disease or disorder

#560
20210069273
2021-03-11

Combination of a retinoid and an extract of (L.) gaertn

#561
20210069214
2021-03-11

TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID FOR THE TREATMENT OF PSORIASIS IN PEDIATRIC PATIENTS

#562
20210052606
2021-02-25

Non-hormonal steroid modulators of NF-kB for treatment of disease

#563
20210046093
2021-02-18

Optimizing Mifepristone Absorption

#564
20210046092
2021-02-18

LOW DOSE COMPOSITIONS OF ARAMCHOL SALTS

#565
20210046091
2021-02-18

Uses of oxygenated cholesterol sulfates (OCS)

#566
20210046090
2021-02-18

Uses of ergosterol combined with gefitinib, preparation methods of liposome and freeze-dried powder thereof

#567
20210040138
2021-02-11

OXYSTEROLS AND METHODS OF USE THEREOF

#568
20210038528
2021-02-11

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

#569
20210030771
2021-02-04

COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER

#570
20210030770
2021-02-04

LITHIUM CHOLESTEROL COMPOSITIONS, INCLUDING, BUT NOT LIMITED TO LITHIUM CHOLESTEROL SULFATE COMPOSITIONS, AND METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND NEUROLOGICAL DISORDERS

#571
20210030677
2021-02-04

Treatment of pneumonia

#572
20210016027
2021-01-21

Breath actuated inhaler

#573
20210008123
2021-01-14

COMPOSITIONS AND METHODS OF TREATING LIVER DISEASE

#574
20210000972
2021-01-07

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

#575
20210000867
2021-01-07

NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING

#576
20200405735
2020-12-31

Methods and pharmaceutical compositions for treating peripheral demyelinating diseases

#577
20200405733
2020-12-31

Topical formulations comprising a steroid

#578
20200397803
2020-12-24

TREATMENT OF FIBROSIS USING FXR LIGANDS

#579
20200397793
2020-12-24

Pharmaceutical compositions and methods of treating cardiovascular diseases

#580
20200392177
2020-12-17

Compositions and methods for treating CNS disorders

#581
20200390787
2020-12-17

Methods and compositions of bile acids and salts for reduction of fat

#582
20200390786
2020-12-17

Compositions and methods for treating ovarian tumors

#583
20200385690
2020-12-10

Cultivation of human noroviruses

#584
20200384070
2020-12-10

Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases

#585
20200384003
2020-12-10

TRITERPENOID-CONTAINING PHARMACEUTICAL COMPOSITION AND USE THEREOF

#586
20200384000
2020-12-10

Methods of treating residual lesions of vascular anomalies

#587
20200383906
2020-12-10

HORMONAL CONTRACEPTION USING A VAGINAL RING WHICH RELEASES ESTRIOL AND TRIMEGESTONE

#588
20200383368
2020-12-10

Methods and products to provide oral nutritional care to subjects with dementia

#589
20200381097
2020-12-03

METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS

#590
20200378876
2020-12-03

Composition for biological tissue transparency and method for biological tissue transparency using same

#591
20200376007
2020-12-03

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

#592
20200376005
2020-12-03

SHIP INHIBITION TO COMBAT OBESITY

#593
20200376004
2020-12-03

AMORPHOUS ONAPRISTONE COMPOSITIONS AND METHODS OF MAKING THE SAME

#594
20200376003
2020-12-03

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLESTEROL GALLSTONE COMPRISING URSODEOXYCHOLIC ACID (UDCA) AND OMEGA-3 FATTY ACID, AND PROCESS FOR PRODUCING THE SAME

#595
20200368351
2020-11-26

Inactivating bacteria with electric pulses and antibiotics

#596
20200368254
2020-11-26

Lipid-like nanocomplexes and uses thereof

#597
20200368253
2020-11-26

Use of CSA compounds to stimulate stem cells and hair growth

#598
20200368199
2020-11-26

Composition containing sumo inhibitor and application

#599
20200368152
2020-11-26

Liquid depot for non-invasive sustained delivery of agents to the eye

#600
20200360403
2020-11-19

OPTHALMIC COMPOSITIONS FOR INHIBITING CLOUDING OF THE OCULAR LENS